Clinical Evaluation
The sequence: screen, assess, diagnose, place
Clinical evaluation in addiction counseling follows a sequence, and exam items often test whether you know where each step belongs. Screening is brief and tells you only whether a problem probably exists. Assessment is comprehensive, ongoing, and biopsychosocial. Diagnosis and level-of-care placement follow the assessment, not the screen.
Screening instruments include the AUDIT (10 items, alcohol), CAGE (4 items), DAST-10, and brief mental health screens such as the PHQ-9 and GAD-7. A favorite trap is offering the Addiction Severity Index (ASI) as a screening test - it is a structured assessment interview, not a screen.
What a complete assessment covers
Substance use history (age of first use, quantity/frequency, patterns, prior treatment, longest abstinence), withdrawal risk, medical and psychiatric status, family and social history, legal, vocational, educational, spiritual, and client strengths. Collateral reports, records, and laboratory data (urine drug screen, breath testing, EtG, CDT, GGT) add corroboration, but the clinical interview and self-report remain the core.
ASAMs six dimensions
Map findings onto the ASAM Criteria: (1) intoxication and withdrawal potential, (2) biomedical conditions, (3) emotional/behavioral/cognitive conditions, (4) readiness to change, (5) relapse/continued use potential, (6) recovery and living environment. Items frequently ask which dimension a finding belongs to - read the stem carefully.
DSM-5-TR substance use disorder requires at least 2 of 11 criteria within 12 months: 2 to 3 mild, 4 to 5 moderate, 6 or more severe.
Traps: missing suicide risk, underestimating withdrawal danger (alcohol and benzodiazepine withdrawal can be fatal), diagnosing without ruling out other explanations, and ignoring co-occurring disorders.
Rule of thumb: screen, assess, diagnose, place - and never assign a level of care your written assessment cannot justify.